Imunon (IMNN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.02, -3.77% vs the prior close of $1.06.
- Volume 55.51K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IMNN slides 3.8% to $1.02, a 52-week low. Closed at $1.02, -3.77% vs the prior close of $1.06. Day range $1.01–$1.05, opened at $1.05.
IMNN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — IMNN slides 3.8% to $1.02, a 52-week low
- Closed at $1.02, -3.77% vs the prior close of $1.06. Day range $1.01–$1.05, opened at $1.05.
- Volume was 55.51K shares, 0.5x its 50-day average of 102.74K — lighter than usual.
- Price is -28.5% vs its 50-day average ($1.43) and -57.0% vs its 200-day average ($2.37).
- 52-week range $0.96–$5.29; today's close sits at 1% of that range, 80.7% below the 52-week high.
Oct 15, 2026 — IMNN rises 1.9% to $1.06
- Closed at $1.06, +1.92% vs the prior close of $1.04. Day range $1.03–$1.07, opened at $1.03.
- Volume was 39.20K shares, 0.4x its 50-day average of 102.86K — lighter than usual.
- Price is -26.3% vs its 50-day average ($1.44) and -55.6% vs its 200-day average ($2.39).
- 52-week range $0.96–$5.29; today's close sits at 2% of that range, 80.0% below the 52-week high.
Oct 14, 2026 — IMNN dips 2.8% to $1.04, a 52-week low, 3 down days in a row
- Closed at $1.04, -2.80% vs the prior close of $1.07. Day range $1.03–$1.08, opened at $1.08.
- Volume was 18.90K shares, 0.2x its 50-day average of 104.45K — lighter than usual.
- Price is -28.2% vs its 50-day average ($1.45) and -56.7% vs its 200-day average ($2.40).
- 52-week range $0.96–$5.29; today's close sits at 2% of that range, 80.3% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — IMNN ends flat (+0.0%) to $1.07
- Closed at $1.07, +0.00% vs the prior close of $1.07. Day range $1.01–$1.08, opened at $1.07.
- Volume was 39.60K shares, 0.4x its 50-day average of 104.39K — lighter than usual.
- Price is -26.8% vs its 50-day average ($1.46) and -55.6% vs its 200-day average ($2.41).
- 52-week range $0.96–$5.29; today's close sits at 3% of that range, 79.8% below the 52-week high.
Oct 12, 2026 — IMNN dips 0.9% to $1.07
- Closed at $1.07, -0.93% vs the prior close of $1.08. Day range $1.03–$1.10, opened at $1.06.
- Volume was 42.50K shares, 0.4x its 50-day average of 104.54K — lighter than usual.
- Price is -27.3% vs its 50-day average ($1.47) and -55.8% vs its 200-day average ($2.42).
- 52-week range $0.96–$5.39; today's close sits at 2% of that range, 80.1% below the 52-week high.
Oct 9, 2026 — IMNN rises 0.9% to $1.08 on 2.1x normal volume
- Closed at $1.08, +0.93% vs the prior close of $1.07. Day range $0.96–$1.12, opened at $1.09.
- Volume was 238.80K shares, 2.1x its 50-day average of 113.07K — unusually heavy trading.
- Price is -27.1% vs its 50-day average ($1.48) and -55.6% vs its 200-day average ($2.43).
- 52-week range $0.96–$5.39; today's close sits at 3% of that range, 80.0% below the 52-week high.
Oct 8, 2026 — IMNN slides 6.1% to $1.07, a 52-week low
- Closed at $1.07, -6.14% vs the prior close of $1.14. Day range $1.03–$1.18, opened at $1.15.
- Volume was 131.20K shares, 1.2x its 50-day average of 111.22K.
- Price is -28.3% vs its 50-day average ($1.49) and -56.3% vs its 200-day average ($2.45).
- 52-week range $1.03–$5.40; today's close sits at 1% of that range, 80.2% below the 52-week high.
Oct 7, 2026 — IMNN rises 1.8% to $1.14
- Closed at $1.14, +1.79% vs the prior close of $1.12. Day range $1.10–$1.16, opened at $1.12.
- Volume was 107.30K shares, 1.0x its 50-day average of 109.70K.
- Price is -24.1% vs its 50-day average ($1.50) and -53.7% vs its 200-day average ($2.46).
- 52-week range $1.10–$5.40; today's close sits at 1% of that range, 78.9% below the 52-week high.
Oct 6, 2026 — IMNN slides 9.7% to $1.12, a 52-week low, 3 down days in a row
- Closed at $1.12, -9.68% vs the prior close of $1.24. Day range $1.12–$1.28, opened at $1.24.
- Volume was 86.40K shares, 0.8x its 50-day average of 109.56K.
- Price is -25.8% vs its 50-day average ($1.51) and -54.7% vs its 200-day average ($2.47).
- 52-week range $1.12–$5.40; today's close sits at 0% of that range, 79.3% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — IMNN slides 3.1% to $1.24, a 52-week low
- Closed at $1.24, -3.12% vs the prior close of $1.28. Day range $1.22–$1.32, opened at $1.30.
- Volume was 82.60K shares, 0.8x its 50-day average of 109.74K.
- Price is -18.3% vs its 50-day average ($1.52) and -50.1% vs its 200-day average ($2.49).
- 52-week range $1.22–$5.55; today's close sits at 0% of that range, 77.7% below the 52-week high.
Oct 2, 2026 — IMNN slides 3.0% to $1.28, a 52-week low
- Closed at $1.28, -3.03% vs the prior close of $1.32. Day range $1.26–$1.38, opened at $1.35.
- Volume was 94.80K shares, 0.9x its 50-day average of 110.96K.
- Price is -16.0% vs its 50-day average ($1.52) and -48.8% vs its 200-day average ($2.50).
- 52-week range $1.26–$5.55; today's close sits at 0% of that range, 76.9% below the 52-week high.
IMNN latest news & SEC filings
Every SEC filing by or about IMNN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Tardugno Michael H received an award of 7,800 shares at $1.08 (≈$8.42K) on Oct 9, 2026; now holds 111,721
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lindborg Stacy received an award of 2,977 shares at $1.08 (≈$3.22K) on Oct 9, 2026; now holds 116,174
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Faller Douglas Vincent received an award of 1,249 shares at $1.08 (≈$1.35K) on Oct 9, 2026; now holds 46,927
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Tardugno Michael H received an award of 7,169 shares at $1.41 (≈$10.11K) on Sep 25, 2026; now holds 103,921
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lindborg Stacy received an award of 6,697 shares at $1.41 (≈$9.44K) on Sep 25, 2026; now holds 113,197
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Faller Douglas Vincent received an award of 4,390 shares at $1.41 (≈$6.19K) on Sep 25, 2026; now holds 45,678
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$2.81M (prior year -$2.74M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.54 (prior year -$2.15) (loss narrowed vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade IMNN
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 31, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.56% (largest 9.7%). That is a volatile stock.
- Liquidity: about 120.03K shares (≈$122.43K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.02 vs a range of $0.96–$5.29 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 115:100 on Aug 7, 2025, 1:15 on Jul 25, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 24 sales; latest: Susan Eylward sold 2,525 shares on Aug 31, 2026.
- Latest filings: 8-K Sep 29, 2026; 8-K Aug 11, 2026; 10-Q Aug 11, 2026.
- Share count: 5.61M shares outstanding (Aug 10, 2026), +156.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
IMNN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.05 | 1.05 | 1.01 | 1.02 | 55.51K |
| Oct 15, 2026 | 1.03 | 1.07 | 1.03 | 1.06 | 39.20K |
| Oct 14, 2026 | 1.08 | 1.08 | 1.03 | 1.04 | 18.90K |
| Oct 13, 2026 | 1.07 | 1.08 | 1.01 | 1.07 | 39.60K |
| Oct 12, 2026 | 1.06 | 1.10 | 1.03 | 1.07 | 42.50K |
| Oct 9, 2026 | 1.09 | 1.12 | 0.96 | 1.08 | 238.80K |
| Oct 8, 2026 | 1.15 | 1.18 | 1.03 | 1.07 | 131.20K |
| Oct 7, 2026 | 1.12 | 1.16 | 1.10 | 1.14 | 107.30K |
| Oct 6, 2026 | 1.24 | 1.28 | 1.12 | 1.12 | 86.40K |
| Oct 5, 2026 | 1.30 | 1.32 | 1.22 | 1.24 | 82.60K |
| Oct 2, 2026 | 1.35 | 1.38 | 1.26 | 1.28 | 94.80K |
| Oct 1, 2026 | 1.29 | 1.39 | 1.26 | 1.32 | 138.00K |
| Sep 30, 2026 | 1.28 | 1.33 | 1.28 | 1.29 | 126.40K |
| Sep 29, 2026 | 1.37 | 1.42 | 1.29 | 1.34 | 157.10K |
| Sep 28, 2026 | 1.43 | 1.44 | 1.36 | 1.38 | 108.60K |
| Sep 25, 2026 | 1.34 | 1.45 | 1.34 | 1.41 | 91.30K |
| Sep 24, 2026 | 1.44 | 1.45 | 1.30 | 1.35 | 184.10K |
| Sep 23, 2026 | 1.54 | 1.57 | 1.42 | 1.47 | 216.50K |
| Sep 22, 2026 | 1.43 | 1.59 | 1.43 | 1.51 | 329.00K |
| Sep 21, 2026 | 1.36 | 1.47 | 1.35 | 1.43 | 112.80K |
About Imunon
Imunon (IMNN) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in LAWRENCEVILLE, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 749647.
IMNN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Donald P Braun | Director | Aug 4, 2026 |
| James E Dentzer | Director | Aug 4, 2026 |
| Frederick J. Fritz | Director | Aug 4, 2026 |
| Stacy Lindborg | President and CEO | Sep 28, 2026 |
| Christine A Pellizzari | Director | Aug 4, 2026 |
| Michael H Tardugno | Executive Chairman of Board | Sep 28, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Khursheed Anwer | Chief Scientific Officer | Jan 6, 2026 |
| Joshua Blacher | CFO | Jul 7, 2026 |
| Kimberly Bragg | CFO | Jan 6, 2026 |
| Jeffrey Wayne Church | CFO | Jan 20, 2026 |
| Susan Eylward | General Counsel and Corp Sec | Sep 1, 2026 |
| Douglas Vincent Faller | Chief Medical Officer | Sep 28, 2026 |
| Stacy Lindborg | President and CEO | Sep 28, 2026 |
| Michael H Tardugno | Executive Chairman of Board | Sep 28, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 31, 2026 | Susan Eylward | Sale | 2,525 | $1.56 |
| Aug 31, 2026 | Susan Eylward | Sale | 2,525 | $1.56 |
| Aug 31, 2026 | Susan Eylward | Sale | 2,525 | $1.56 |
| Aug 31, 2026 | Susan Eylward | Sale | 2,525 | $1.56 |
| Aug 17, 2026 | Susan Eylward | Sale | 2,449 | $1.63 |
| Aug 17, 2026 | Susan Eylward | Sale | 2,449 | $1.63 |
| Aug 17, 2026 | Susan Eylward | Sale | 2,449 | $1.63 |
| Aug 17, 2026 | Susan Eylward | Sale | 2,449 | $1.63 |
| Aug 3, 2026 | Susan Eylward | Sale | 2,541 | $1.57 |
| Aug 3, 2026 | Susan Eylward | Sale | 2,541 | $1.57 |
| Aug 3, 2026 | Susan Eylward | Sale | 2,541 | $1.57 |
| Aug 3, 2026 | Susan Eylward | Sale | 2,541 | $1.57 |
| Jul 20, 2026 | Susan Eylward | Sale | 2,150 | $1.78 |
| Jul 20, 2026 | Susan Eylward | Sale | 2,150 | $1.78 |
| Jul 20, 2026 | Susan Eylward | Sale | 2,150 | $1.78 |
IMNN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-14.50M | -6.83 | $-13.90M |
| Dec 31, 2024 | — | $-18.62M | -16.94 | $-18.85M |
| Dec 31, 2023 | — | $-19.51M | -2.16 | $-19.02M |
| Dec 31, 2022 | $500.00K | $-35.90M | -5.03 | $-23.10M |
| Dec 31, 2021 | $500.00K | $-20.77M | — | $-16.22M |
Latest balance sheet: total assets $14.99M, total liabilities $10.80M, cash $6.86M (as of Jun 30, 2026).
IMNN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $1.61 |
| May 12, 2026 | 8-K Item 2.02 (results) | $2.70 |
| Mar 31, 2026 | 8-K Item 2.02 (results) | $2.94 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $4.16 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $7.62 |
| May 12, 2025 | 8-K Item 2.02 (results) | $10.70 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $10.57 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $10.70 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on IMNN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.